Understanding your target disease’s epidemiology is the foundation of a credible evidence strategy. Our epidemiology experts help you build a clear picture of disease burden, patient populations, and unmet need so you can size the opportunity and focus on what matters most.

We work with your team to identify evidence gaps, define the right subpopulations, and translate epidemiologic insights into practical development choices. That foundation strengthens your value story and helps prioritize evidence generation where it will have the greatest impact.

Securing favorable reimbursement and market access depends on more than strong efficacy results. It depends on demonstrating comparative clinical value in the way HTA bodies and payers expect. Our Evidence & Value team helps biotech teams align early on comparators, endpoints, and the evidence narrative needed to support access decisions.

As the EU HTA Regulation introduces Joint Clinical Assessments (JCAs), timing and alignment matter even more. For a practical overview of what is changing and how to prepare, see our EU HTA Regulation guide.

Effective evidence generation requires collaboration and alignment across multiple functions. At SSI Strategy, our Evidence & Value team bridges these critical stakeholders, ensuring your evidence strategy is integrated with your overall product development plan. We work with your teams to develop a unified vision of success and a roadmap for achieving it. 

By breaking down silos and driving cross-functional alignment, we help you optimize resource allocation, minimize delays, and accelerate your innovative therapy's path to market. Our comprehensive expertise provides valuable insights that inform your evidence generation strategy. 

Choosing SSI Strategy as your Evidence & Value partner gives you a trusted ally with a proven track record of delivering strategic insights and driving evidence generation excellence. Our combination of deep epidemiology expertise, HTA and payer knowledge, cross-functional collaboration, and comprehensive understanding of the drug development process enables us to provide tailored solutions that address your specific challenges and goals. 

We think strategically, anticipate evidence needs, and design innovative solutions that maximize your therapy's value. By leveraging our 360-degree expertise and emphasizing early value consideration, we help you bring your treatment to patients faster and with greater success.